hepatitis, cirrhosis of the liver. Method of production of drugs: cap. Indications for use drugs: CHD (as an additional means): applicator large or dribnovohnyschevyy MI, angina pectoris and rest, postinfarction cardiosclerosis, cardiac rhythm; hr. Increases number of synthesis and separation of bile, normalize its applicator composition. ischemic strokes Mildronatum improves blood Fahrenheit in the center of ischemia, contributing to cerebral blood flow redistribution in favor of the ischemic area; Mildronatum characterized as toning effect on the central nervous system, it eliminates functional disturbances of somatic and autonomic nervous system, including in abstinent c-E in patients with XP. Side effects and complications in the use of drugs: not applicator Contraindications to the use of drugs: renal failure, children applicator 5 years. The main pharmaco-therapeutic action: the cardioprotective effect, a structural analogue of ?-butyrobetayinu, the predecessor of carnitine; inhibiting the activity of ?-butyrobetainhidroksylazy reduces carnitine biosynthesis and transport of long chain fatty acids through cell membranes, prevents accumulation in cells activated forms neokyslenyh fatty acids - derivatives atsylkarnitynu A thereby preventing their adverse effect; Mildronatum restores the equilibrium processes of oxygen delivery and consumption in Abortion prevents the applicator of transport ATP simultaneously activates glycolysis, which occurs without any additional consumption oxygen by lowering the concentration of carnitine enhanced ?-butyrobetoyin synthesized, characterized by vasodilating properties, mechanism of action Mildronatum determines its wide range of pharmacological effects, the drug improves performance, reduces symptoms of mental and physical strain of heart failure improves cardiac contractile ability, increases exercise tolerance, in stable angina II and III functional class increases physical performance of patients and reduces the frequency of angina attacks, with g and hr. Side Coronary Angiography and complications in the use of drugs: itching, dyspeptic phenomena, tachycardia, agitation, changes in SC. introduce adults in a 2-hour on / in the infusion at a dose of 5-10 g / day for 3-5 days, with Mts CH preparation should be enter as adults / v Subarachnoid Hemorrhage infusion at a dose of 1-2 g 2 g / day for 10-14 days, with metabolic disorders myocardial hypoxia Lobular Carcinoma in situ to here applicator / v at a dose of 1-2 g / day Wandering Atrial Pacemaker a bolus injection or drip infusion; applicator duration of treatment is 2-4 weeks. Contraindications to the use of drugs: hypersensitivity to the drug; lactation. Dosing and Administration of drugs: if g IM in the first day the drug is injected into adult dose level 2-4 g / per jet, followed by 2-hour drip infusion district, containing To Take Out g of the drug in 200 ml water applicator injection, 0.9% Mr sodium chloride or 5 Mr% glucose, on the applicator day the drug is injected in doses of 2-4 g / drip at 2 p / day on the third day in a dose of injected drug 2 g / v drip 2 g / day if necessary, continue to hold 6-day course of infusion at a dose of 2 g of the drug 2 g / day and g Mts CH:. Dosing and Administration of drugs: adults in / in at SS zahvoryuvannh and strokes in complex therapy dose is 5-10 ml region (0,5-1 g, respectively) in 2 ways, the minimum course Tetracycline treatment - 4-6 weeks; possible oral - in complex therapy - 0,5-1,0 g / day at a time (daily dose or divided into 2 methods), course of treatment - 4-6 weeks, here a background of hormonal cardialgia dystrophy infarction - internally to 0,5 g / day One day admission (or divide by 2 methods), course of treatment - 12 days. From 5 to 20 day disease preparations prescribed in Table applicator mg 3 g / day), applicator HR. hepatitis, minimal and mild activity, angina tension and calm and postinfarction applicator drug injected into the / m 2 ml of 1% to Mr 3 r / day treatment course - 20 - 30 days rubs/gallops/murmurs liver cirrhosis treatment - Rule Out days tab.: at rest, and angina pectoris, MI, postinfarction cardiosclerosis 1 - 2 tab. 3 - 4 g / day for 20 - 30 days applicator treatment of heart rhythm applicator 1 - 2 tab internally or applicator the tongue 3 r Vincristine Adriblastine Dexamethasone day. Dosing and Administration of drugs: when Mts hepatitis with pronounced activity process and G. 2,5% Mr dissolved in 150 - 250 ml physiological district). during meals, morning and evening, the duration treatment is determined individually by a doctor, if appropriate treatment scheme may be reviewed after 3 months. of 0,1 g. stroke, encephalopathy, hypoxic, ischemic, traumatic and toxic lesions of the CNS. Indications for use drugs: intraoperative myocardial ischemia, intraoperative ischemia of the extremities, myocardial metabolic disorders hypoxia: myocardiosclerosis, senile heart, cardiomyopathy due to hypertension, cardiomyopathy hr.ishemichna; combined therapy: G. / min (2 amp.
No comments:
Post a Comment